Perrigo Rogaine Foam ANDA May Help Extend Record Growth
This article was originally published in The Tan Sheet
Executive Summary
Perrigo's regulatory green light to market the first OTC generic of Men's Rogaine Foam further extends the pipeline that has kept the firm on a streak of record earnings.
You may also be interested in...
Perrigo To Launch Private Label Mucinex, Prevacid, With An Eye On Lipitor
Private label giant Perrigo is readying generic competitors to Reckitt Benckiser’s Mucinex and Takeda Pharmaceuticals’ Prevacid, CEO Joseph Papa says.
Perrigo's Zantac 150 Generic Marks First Approval From Remediated Plant
Perrigo will launch private-label equivalents of OTC heartburn reliever Zantac 150 this summer.
In Brief
FDA proposes laxative monograph change